CapitalBio
http:/www.capitalbio.com
Medical electronics
Capital Biobo Bio Group Co., Ltd. and Biochip Beijing National Engineering Research Center (hereinafter referred to as "Boao Bio") were established on September 30, 2000, with the care and support of the State Council, the Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Education, the Ministry of Health and the leadership of Beijing, and with the support of Tsinghua University, the Central China University of Science and Technology, the Chinese Academy of Medical Sciences and the Academy of Military Medical Sciences. 。 Its predecessor is Tsinghua University Biochip Research and Development Center. In 2014, Boao Biology formed four research institutes (Research Institute of Conversion Medicine, Research Institute of Engineering Conversion, Research Institute of Health Sciences, Research Institute of Biomedical Information), five wholly-owned subsidiaries (Beijing Boao Jingdian Biotechnology Co., Ltd., Beijing Boao Medical Inspection Ownership Co., Ltd., Boao Yihe Health Science and Technology Co., Ltd., Dongguan Boao) due to its development needs. The group operation structure of Muhua Gene Technology Co., Ltd. and Chengdu Boao Xinjing Medical Technology Co., Ltd. As one of the member companies of Tsinghua Holdings, Boao Biology is committed to developing and providing innovative technology products and services in the field of life sciences and integrated medicine (including forecasting, prevention and individualized medicine). Three research institutes at the group headquarters have successfully developed biochips and related reagent consumables, instruments and equipment, software databases, and life sciences services using independent innovation technology. Five series of products and services with independent intellectual property rights, such as clinical laboratory services, more than 10 of which are pioneered internationally, and more than 200 patents have been authorized globally.
